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Abstract: Allergic airway inflammation is charac-
terized by peribronchial eosinophil accumulation
within the submucosa surrounding the airway. The
initial induction ofimmunoglobulin E (IgE)-mediated
mast cell degranulation, up-regulation of adhesion
molecules, and the production of inflammatory and
chemotactic cytokines, leading to the infiltration of
specific leukocyte subsets, is orchestrated in a se-
quential manner. The activation and degranulation
of local mast cell populations is an immediate airway
response mediated both by antigen-specific, surface
bound IgE and by cytokine-induced activational
pathways. Subsequently the infiltration and activa-
tion of effector leukocytes (neutrophils and eosino-
phils) mediated by the persistant activation of
allergen-specific T cells leads to pathological maui-
festations within the lung and airway. The develop-
ment of appropriate animal models to dissect the
critical mechanisms involved in antigen-induced air-
way pathology is crucial for the development of
efficacious therapies. We have utilized a model of
allergic airway inflammation induced by intratra-
cheal challenge with parasite (Schistosoma mansoni)
egg antigen in presensitized mice. This model has
proven useful in the assessment of eosinophil recruit-
ment and has identified key cytokines involved in
leukocyte elicitation. These cytokines include inter-
leukin-4 and tumor necrosis factor, which appear to
act as early response mediators, as well as C-C
chemokines, macrophage inflammatory protein- 1 a,
and RANTES, which act directly on eosinophil re-
cruitment. In addition, we have found that both
C-X-C and C-C chemokines are expressed in pulmo-
nary-derived mast cells, suggesting an important con-
tribution to leukocyte responses in the allergic
airway. J. Leukoc. Biol. 59: 13-17; 1996.
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INTRODUCTION
Allergic pulmonary diseases affect a significant proportion
of the population worldwide and include disorders such as
asthma, pulmonary eosinophilia, and bronchopulmonary
mucomycosis [i]. The long-term pathological effects of
asthma have been attributed, in part, to infiltrating leuko-
cytes that surround the bronchus and infiltrate into the
airway [2-4]. The immune response associated with
asthma has been described as having histopathological fea-
tures of a chronic cell-mediated immune reaction, charac-
terized by the infiltration of the bronchial mucosa with
neutrophils, basophils, eosinophils, macrophages, and
lymphocytes [2]. Eosinophils have been reported to be the
primary cell responsible for the induction of bronchial mu-
cosal injury and are thought to contribute to the bronchial
obstruction associated with the asthmatic response [1, 2, 3,
4]. In atopic asthmatic inflammation, a concomitant pro-
duction of Th2 cell type cytokines interleukin [(IL)-4, IL-
5] has been observed, which correlates with disease
intensity and eosinophil infiltration [5-i3]. In animal
models, the depletion of CD4 T cells results in an abro-
gated eosinophilia and a reduction in airway hyperreactiv-
ity [14]. Thus it appears that T cells with a Th2 cytokine
phenotype mediate and maintain allergic airway responses,
such as in atopic asthma.
The elicitation of leukocyte subsets has been attributed
with the production of several different chemotactic fac-
tors. Leukotriene B4 (LTB-4), platelet-activating factor
(PAF), and C5a have been defined as nonspecific
chemoattractants responsible for leukocyte recruitment,
with the ability to elicit not only neutrophils, but also
mononuclear cells and eosinophils. Recently, several labo-
ratories have identified specific neutrophil, mononuclear,
and eosinophil chemotactic cytokines (chemokines). These
potent chemoattractants are divided into two distinct su-
pergene families, C-X-C and C-C, designated by the posi-
tion of the first two cysteine amino acid residues [15, 16].
The C-X-C family of chemokines is primarily chemotactic
for neutrophils and is typified by IL-8. The C-C family of
chemokines is primarily chemotactic for mononuclear
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phagocytes, lymphocytes, and eosinophils and contains
closely related proteins: monocyte chemoattractant pro-
tein-b,2,3 (MCP-1 ,2,3), macrophage inflammatory protein-
lu (MIP-bu), and RANTES [15]. The C-C family members
are of particular interest in the allergic response, since
there appears to be a strong correlation with the expression
of C-C chemokines and chronic inflammatory diseases
[16]. In particular, MIP-ba and RANTES may be impor-
tant in the allergic airway response for several reasons.
These proteins have been shown to be chemotactic for
monocytes, differentially chemotactic for lymphocyte sub-
sets [17-19], and more importantly, chemotactic for eosi-
nophils in vitro [20]. More recently, a novel C-C
chemokine, MCP-3, has been identified as an extremely
potent eosinophil chemoattractant protein and therefore
implicated in allergic responses [21]. In addition, a novel
C-C chemokine, eotaxin, was detected by use of an allergic
airway model in the guinea pig [22]. The identification of
these eosinophil chemoattractant proteins may serve as
important targets in inflammation for the control of allergic
airway diseases.
Fig. 1. Soluble IL-4 and TNF receptor constructs (provided by Immunex
Corp., Seattle, WA) decrease production ofeosinophil chemotactic cytok-
ines, MIP-la and RANTES. Mice were treated with soluble IL-4 and TNF
receptor constructs 2 h before an intratracheal challenge with SEA. Lungs
were removed and homogenated at 8 h post-challenge, time of peak
chemokine production. RANTES and MIP-la levels were measured in
the samples by specific enzyme-linked immunosorbent assays. Data is
presented as percent of control antibody treated SEA control and repre-
sents the mean ± SE from 5 mice in each group.
Table 1. Immunolocalization of Chemokines in Pulmonary-Derived
Mast Cells








EARLY RESPONSE CYTOKINES IN ALLERGIC
EOSINOPHILIC AIRWAY INFLAMMATION
The release of early response cytokines, IL-b and tumor
necrosis factor (TNF), during a response is crucial for in-
duction of selectin and adhesion molecule expression, the
initiation of cytokine cascades, the up-regulation of spe-
cific chemokines, and the recruitment of leukocyte sub-
sets. The contribution of IL-b and TNF to allergic
eosinophil recruitment has been verified in vivo through
the use of IL-i receptor antagonist protein in a guinea pig
model of eosinophilic airway inflammation [23] and by
soluble TNF receptor treatment in our murine model of
eosinophilic airway inflammation [24]. Increases in TNF
production were observed early during allergen challenge,
between 1 and 8 h. Furthermore, when TNF was neutral-
ized in vivo, both neutrophil (-40%) and eosinophil
(-70%) recruitment were significantly altered [24]. In
these latter studies, inhibition of either IL-b or TNF acti-
vational pathways significantly decreased the eosinophilic
migration into the airway.
In addition to IL-b and TNF, IL-4 released by both mast
cells [25, 26] and antigen-stimulated Th2 cells [bO, 1 b]
can up-regulate VCAM-b expression on vascular endothe-
hum [27] and further contribute to the lymphocyte, mono-
cyte, and eosinophil extravasation. Given the correlation of
Th2 type cytokine (IL-4) production and eosinophilic in-
flammation in airways of asthmatics, this latter pathway
may constitute a significant contribution to the overall leu-
kocyte recruitment. This cascade has been verified in ani-
mal models of allergic airway eosinophilia. We have
previously detected substantial levels of IL-4 in the BAL
fluid of mice by 8-24 h post intratracheal challenge with
allergen [28]. In this Schsstosoma manoni egg antigen
(SEA) model, mice treated with antibodies to IL-4 demon-
strated a significant decrease in leukocyte recruitment,
which nearly abrogated the eosinophilic airway inflamma-
tion. These data suggested that the early production of IL-4
may be critical to development of an allergic eosinophilic
response. In separate experiments, using an ovalbumin-in-
duced airway eosinophil model, IL-4-deficient mice dem-
onstrated a significantly attenuated inflammatory airway
response [29]. These animal models provide initial evi-
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Table 2. Neutralization of ENA-78 Blocks Mast Cell
Sonicate-Induced Neutrophil Infiltration Into the Airways of Normal
Mice and During Allergen Challenge in Allergic Mice
Antibody treatment
% Neutrophi 1 infiltration
Mast cell sonicate’ Allergen model2
Control Ab 87.2±2.9 75.3±5.0
anti-ENA-78 46.4±7.9 48.3±6.4
‘Mast cells 2 X 1O were sonicated, and the cell-free supematant (25j.tl)
combined with control or anti-ENA.78 antobody (1:20 dilution) was injected
intratracheally into normal mice. One-milliliter BAL fluid samples were exam-
med 4 h post-sonicate injection.
2Control or anti.ENA-78 antibody was injected intraperitoneally into allergic
mice 2 h prior to allergen challenge. One milliliter BAL fluid smaples were taken
8 h post-challenge, the time of peak neutrophil migration.
dence that Th2 (IL-4, IL-5) type inflammation observed in
allergic airway responses have a significant relationship to
the subsequent elicitation of leukocyte subpopulations. Al-
though TNF and IL-4 are not by themselves chemotactic,
they can up-regulate the production of chemotactic factors
and adhesion molecules and appear to have complimentary
critical roles in allergic airway inflammation.
c-C chemokines in allergic eosinophilic airway
inflammation
The production of chemokines during asthmatic responses
in humans may contribute specifically to the influx of eos-
inophils. Eosinophils have been implicated as a major ef-
fector cell inducing airway injury and subsequent late
phase reactivity in asthmatics [1, 2]. A number of the C-C
chemokines appear to preferentially recruit human eosino-
phils in vitro, including RANTES, MIP-la, and MCP-3
[20, 21]. In addition, IL-8, a C-X-C chemokine, also ap-
pears to have some activity on eosinophil recruitment [30].
The measurement of MIP-la [31] and RANTES protein in
lung homogenates or BAL fluids has demonstrated in-
creased production during the development of the eosino-
philic response, peaking between 8 and 48 h post airway
allergen challenge. The cellular source of the two chemok-
ines was determined by immunohistochemical localization.
MIP-la appears to be produced by macrophages and air-
way epithelial cells [31], whereas RANTES appears to be
produced primarily by type II epithelial cells within the
lung. In addition, the production of both MIP-la and
RANTES was significantly decreased in lung homogenates
when either IL-4 or TNF were neutralized in vivo by use of
soluble cytokine receptors (Fig. 1). These studies indicate
that these early response cytokines up-regulated eosino-
phil recruitment, at least in part, via induction of chemok-
me production. Furthermore, when either MIP-lu or
RANTES was neutralized in vivo, a significant decrease in
airway eosinophilia was observed with both anti-MIP-la
(>50%) [34] and anti-RANTES (>60%) antibody admini-
stration, indicating that multiple chemokines contribute to
the recruitment of eosinophils. In addition, when lung his-
tology of the control, anti-MIP-la, and anti-RANTES anti-
body-treated animals was examined there was still a
Fig. 2. The progression ofallergen-specific airway inflammation in sensitized mice. The initiation ofthe allergic airway response likely entails multiple
mechanisms ofactivation, including antigen-specific IgE-mediated mast cell degranulation and T lymphocyte activation. These allergen specific events
lead to the production of multiple inflammatory (TNF-a, IL-4) and chemotactic (MIP-la, RANTES) cytokines that probably facilitate leukocyte
recruitment and airway reactivity.
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considerable peribronchial mononuclear cell infiltrate.
However, in these same mice there was a paucity of eosi-
nophils present in the lung compared with control anti-
body-treated mice. Interestingly, passive immunization
with anti-MCP-1 did not reduce the influx of eosinophils
into the airway, thus demonstrating chemokine specificity
for the eosinophilic response. These latter observations
may begin to outline that C-C chemokines, which have
overlapping functions, may play specific roles in particular
types of inflammation (i.e., eosinophil but not mononuclear
cell recruitment). The use of the SEA animal model, which
has many of the attributes of human asthma, begins to
outline the specific role that C-C chemokines play in aller-
gic airway inflammation, leading to eosinophil recruitment.
Airway-derived mast cells contain C-X-C and C-C
chemokines
Mast cell activation likely comprises a major role in the
initiation of the airway response during allergen lung chal-
lenge. Immunoglobulin E (IgE)-mediated activation of
mast cells induces immediate degranulation and release of
inflammatory mediators, including histamine, seratonin,
PAF, leukotrienes (LTB4, C4, D4, and E4), prostaglandin
D2, as well as several other inflammatory mediators [32].
These mediators can induce immediate responses, such as
vascular permeability, bronchoconstriction, edema, and
mucus secretion, all of which contribute to decreased pul-
monary function [32]. In addition, these early mediators
have the ability to induce the recruitment of additional
leukocytes into the lung as well as activate local cell popu-
lations for the production of additional cytokines. Other
cytokines can also be produced by mast cells. Recent in-
vestigations have identified the production of IL-i, IL-4,
and TNF upon mast cell degranulation. Thus mast cells are
a primary source of potent early response cytokines capa-
ble of initiating the expression of adhesion molecules and
cytokine cascades, leading to increased leukocyte recruit-
ment [33]. Early studies described mast cell-derived neu-
trophil and eosinophil chemotactic factors capable of
mediating the leukocyte recruitment responses in a non-
specific manner.
More recently, mast cells have been identified as a
source of several chemotactic cytokines, chemokines,
which possess the ability to specifically recruit particular
leukocyte populations. Our laboratory has isolated and
grown airway mast cell populations in vitro using specific
growth factors, stem cell factor, and IL-3. These investiga-
tions have identified the presence of several chemokines in
pulmonary mast cell populations. Table 1 summarizes the
immunohistochemical and/or immunogold localization of
chemokines in pulmonary mast cell lines. These investiga-
tions have identified the mast cell as a significant source
of specific chemokines, MIP-lcx, MCP-1, RANTES, and
ENA-78, with marginal staining of MIP-2 (a functional
murine homolog of IL-8). These findings are in agreement
with early investigations examining the expression of
chemokines in human mast cell populations [34]. To fur-
ther investigate the role of mast cell-derived chemokines
in airway responses, sonicates from pulmonary mast cell
lines were administered intratracheally to normal mice.
When leukocyte infiltration was examined in the airway by
BAL at 4 h post-intratracheal mast cell sonicate admini-
stration, a predominant neutrophil infiltration was oh-
served. The neutrophils constituted 80-90% of the
infiltrate. If the mast cell sonicates were preincubated with
control, anti-ENA-78, or anti-MIP-2 antibodies, only anti-
ENA-78 significantly reduced the neutrophil infiltration
(Table 2). To examine the role of ENA-78 in allergic
airway inflammation we utilized the SEA-induced mouse
model of allergic airway inflammation. When allergic mice
were treated with control, anti-ENA-78, or anti-MIP-2 an-
tibodies before intratracheal SEA (allergen) challenge,
only anti-ENA-78 significantly inhibited neutrophil accu-
mulation. These studies indicated that ENA-78 was a pri-
mary mast cell-derived neutrophil chemotactic factor that
is likely released upon allergen challenge inducing neutro-
phil infiltration. Further studies will examine the role of
mast cell-derived C-C chemokines for mononuclear and
eosinophil recruitment in this allergic mouse model. Alto-
gether, these studies suggest that mast cells have the abil-
ity to induce cytokine-mediated leukocyte infiltration upon
activation and degranulation and constitute a major effec-
tor cell during allergic responses.
Summary
The elucidation of mechanisms involved in leukocyte re-
cruitment during an allergic airway response is paramount
for the understanding and treatment of allergic airway dis-
eases such as asthma. It appears that a sequential produc-
tion of early response cytokines, IL-4 and TNF, leads to
the subsequent production of eosinophil-specific chemok-
ines, MIP-la and RANTES (summarized in Fig. 2). Neu-
tralization studies in experimental models have identified
all four of these cytokines as having a significant role in
eosinophil accumulation in vivo. In addition, the mast cell,
which is primarily activated during allergic responses, pro-
duces both neutrophil and eosinophil-specific chemokines
and therefore constitutes an important source of chemotax-
ins during allergic responses. The identification of specific
target molecules and their cellular sources may lead to
development of novel therapeutic applications that can be
tested for efficacy and function in animal models of inflam-
mation.
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